187 related articles for article (PubMed ID: 29872016)
1. Maslinic acid modulates secreted phospholipase A2-IIA (sPLA2-IIA)-mediated inflammatory effects in macrophage foam cells formation.
Yap WH; Ooi BK; Ahmed N; Lim YM
J Biosci; 2018 Jun; 43(2):277-285. PubMed ID: 29872016
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Human Group IIA-Secreted Phospholipase A2 and THP-1 Monocyte Recruitment by Maslinic Acid.
Yap WH; Ahmed N; Lim YM
Lipids; 2016 Oct; 51(10):1153-1159. PubMed ID: 27540737
[TBL] [Abstract][Full Text] [Related]
3. Maslinic acid suppresses macrophage foam cells formation: Regulation of monocyte recruitment and macrophage lipids homeostasis.
Phang SW; Ooi BK; Ahemad N; Yap WH
Vascul Pharmacol; 2020; 128-129():106675. PubMed ID: 32200116
[TBL] [Abstract][Full Text] [Related]
4. Hawthorn leaf flavonoids alleviate the deterioration of atherosclerosis by inhibiting SCAP-SREBP2-LDLR pathway through sPLA2-ⅡA signaling in macrophages in mice.
Bai X; Wang S; Shu L; Cao Q; Hu H; Zhu Y; Chen C
J Ethnopharmacol; 2024 Jun; 327():118006. PubMed ID: 38442806
[TBL] [Abstract][Full Text] [Related]
5. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
Hanasaki K; Yamada K; Yamamoto S; Ishimoto Y; Saiga A; Ono T; Ikeda M; Notoya M; Kamitani S; Arita H
J Biol Chem; 2002 Aug; 277(32):29116-24. PubMed ID: 12021277
[TBL] [Abstract][Full Text] [Related]
6. 12-HETE is a regulator of PGE
Moreira V; Gutiérrez JM; Lomonte B; Vinolo MAR; Curi R; Lambeau G; Teixeira C
Chem Biol Interact; 2020 Feb; 317():108903. PubMed ID: 31811862
[TBL] [Abstract][Full Text] [Related]
7. Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition.
Ghesquiere SA; Gijbels MJ; Anthonsen M; van Gorp PJ; van der Made I; Johansen B; Hofker MH; de Winther MP
J Lipid Res; 2005 Feb; 46(2):201-10. PubMed ID: 15576846
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of the involvement of Nrf2 in maslinic acid-mediated anti-inflammatory effects in atheroma pathogenesis.
Ooi BK; Phang SW; Yong PVC; Chellappan DK; Dua K; Khaw KY; Goh BH; Pusparajah P; Yap WH
Life Sci; 2021 Aug; 278():119658. PubMed ID: 34048809
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress.
Tietge UJ; Pratico D; Ding T; Funk CD; Hildebrand RB; Van Berkel T; Van Eck M
J Lipid Res; 2005 Aug; 46(8):1604-14. PubMed ID: 15897607
[TBL] [Abstract][Full Text] [Related]
11. Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNFalpha-stimulated human endothelial cells.
Sonoki K; Iwase M; Sasaki N; Ohdo S; Higuchi S; Takata Y; Iida M
Br J Pharmacol; 2008 Apr; 153(7):1399-408. PubMed ID: 18264128
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory Effect of FXa on Secretory Group IIA Phospholipase A2.
Ku SK; Bae JS
Inflammation; 2015; 38(3):987-94. PubMed ID: 25399323
[TBL] [Abstract][Full Text] [Related]
13. Respective contribution of cytosolic phospholipase A2α and secreted phospholipase A
Duchez AC; Boudreau LH; Naika GS; Rousseau M; Cloutier N; Levesque T; Gelb MH; Boilard E
Prostaglandins Other Lipid Mediat; 2019 Aug; 143():106340. PubMed ID: 31129176
[TBL] [Abstract][Full Text] [Related]
14. Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?
Menschikowski M; Hagelgans A; Siegert G
Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):1-33. PubMed ID: 16516807
[TBL] [Abstract][Full Text] [Related]
15. Secreted Phospholipase A
Martin R; Gutierrez B; Cordova C; Roman AS; Alvarez Y; Hernandez M; Cachofeiro V; Nieto ML
Cells; 2020 Feb; 9(2):. PubMed ID: 32046347
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Rho modulates cytokine-induced prostaglandin E2 formation in renal mesangial cells.
Petry C; Fritz G; Pfeilschifter J; Huwiler A
Biochim Biophys Acta; 2004 Mar; 1636(2-3):108-18. PubMed ID: 15164758
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of secretory phospholipase A2 IIa attenuates prostaglandin E2-induced invasiveness in lung adenocarcinoma.
Halpern AL; Kohtz PD; Rove JY; Ao L; Meng X; Fullerton DA; Weyant MJ
Mol Cell Biochem; 2019 Jun; 456(1-2):145-156. PubMed ID: 30684134
[TBL] [Abstract][Full Text] [Related]
18. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation.
Wooton-Kee CR; Boyanovsky BB; Nasser MS; de Villiers WJ; Webb NR
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):762-7. PubMed ID: 14962950
[TBL] [Abstract][Full Text] [Related]
19. Group IIA Secretory Phospholipase A
Akinkuolie AO; Lawler PR; Chu AY; Caulfield M; Mu J; Ding B; Nyberg F; Glynn RJ; Ridker PM; Hurt-Camejo E; Chasman DI; Mora S
Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1182-1190. PubMed ID: 31070471
[TBL] [Abstract][Full Text] [Related]
20. Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet.
Rosengren B; Peilot H; Umaerus M; Jönsson-Rylander AC; Mattsson-Hultén L; Hallberg C; Cronet P; Rodriguez-Lee M; Hurt-Camejo E
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1579-85. PubMed ID: 16601231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
